(Q33649665)

English

Insulin aspart

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

Insulin aspart (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

author name string

Simpson KL

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Spencer CM

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

759-65; discussion 766-7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

https://scigraph.springernature.com/pub.10.2165/00003495-199957050-00013

0 references

Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Action profile of the rapid acting insulin analogue: human insulin B28Asp

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scintigraphic studies in rats. Kinetics of insulin analogues covering wide range of receptor affinities

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo potency of insulin analogues designed for clinical use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor Binding and Tyrosine Kinase Activation by Insulin Analogues With Extreme Affinities Studied in Human Hepatoma HepG2 Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulinkinetic and -dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analogue (B28Asp)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time-action profile of the insulin analogue B28Asp

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10353301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199957050-00013

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33649665&oldid=1528354372"